Team:Aachen/PolicyPractices/Economics
From 2014.igem.org
(→WatsOn) |
(→WatsOn) |
||
Line 101: | Line 101: | ||
</center> | </center> | ||
- | Such low prices with the acceptance of self-building opens a grand new customer market and offers competition to commercial saleable products. Especially in developing counties our ''WatsOn'' could help and its low rebuilding costs are making | + | Such low prices with the acceptance of '''self-building''' opens a grand new customer market and offers competition to commercial saleable products. Especially in developing counties our ''WatsOn'' could help and its low rebuilding costs are making purchase possible. Such those low material costs and the high technical flexibility are making WatsOn to an adequate device for developing countries, community labs and the biohacker scene. In particular for developing countries such a low budget device version bids a good alternative to regular devices for detecting pathogens. With our device institutions in such those countries have an access to modern technology and working methods. |
- | + | ||
- | + | ||
<center> | <center> | ||
{{Team:Aachen/Figure|Aachen_Team_WatsOn_3.png|title=''WatsOn's'' self-made concept makes it available for low budged institutions|width=800px}} | {{Team:Aachen/Figure|Aachen_Team_WatsOn_3.png|title=''WatsOn's'' self-made concept makes it available for low budged institutions|width=800px}} | ||
</center> | </center> | ||
+ | Also for this device we are offering the building plan and also the needed software Measuraty for use. This makes it for institutions and also for amateurs possible to modify the device according to personal progress including for example the range of detectable micro-organisms. As an example it could be possible to detect not just the fluorescent of GFP and iLOV but also important reporter-proteins YFP, CFP or RFP. This would just be possible by changing the filter slides or LEDs | ||
However, please always remind yourself of the respective [https://2014.igem.org/Team:Aachen/Safety safety aspects] when dealing with GMOs and human pathogens. | However, please always remind yourself of the respective [https://2014.igem.org/Team:Aachen/Safety safety aspects] when dealing with GMOs and human pathogens. |
Revision as of 13:06, 17 October 2014
|
|
|